Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs

Jeffrey W. Allen, Patrick W. Mantyh, Kjersti Horais, Nicole Tozier, Scott D. Rogers, Joseph R. Ghilardi, Dasa Cizkova, Marjorie Grafe, Phillip Richter, Douglas A. Lappi, Tony L. Yaksh

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Intrathecal (IT) substance P-Saporin (SP-SAP), a 33-kDa-targeted neurotoxin, produces selective destruction of superficial neurokinin 1 receptor (NK1r)-bearing cells in the spinal dorsal horn. In rats, SP-SAP prevents the formation of hyperalgesia and can reverse established neuropathic pain behavior in rodents. To determine the safety of this therapeutic modality in a large animal model, beagles received bolus IT lumbar injections of vehicle, SP-SAP (1.5, 15, 45, or 150 μg), or a nontargeted preparation of saporin (SAP, 150 μg) for immunohistological analysis of spinal cords. Doses of 15 μg SP-SAP and above produced a significant and equivalent loss of NK1r-bearing cells and dendrites in lumbar laminae II and I compared to vehicle- or SAP-treated animals. Cervical regions in all animals displayed no loss of NK1r immunoreactivity as compared to controls. Total numbers of neurons in the lumbar dorsal horn or alpha-motor neurons in the ventral horn demonstrated no significant changes. No increases in the astrocytic marker glial fibrillary acidic protein were noted following treatment with SP-SAP, suggesting a lack of generalized neurotoxicity. Additional dogs received doses of 1.5-150 μg SP-SAP or SAP and were sacrificed after 28 or 90 days to assess behavioral and physiological parameters. Although some acute motor signs were observed with both SP-SAP and SAP, no long-lasting significant events were noted in any of these animals. These data indicate no adverse toxicity at doses up to 10 times those necessary for producing loss of superficial NK1r-bearing neurons in a large animal model.

Original languageEnglish (US)
Pages (from-to)286-298
Number of pages13
JournalToxicological Sciences
Volume91
Issue number1
DOIs
StatePublished - May 2006

Fingerprint

Neurotoxins
Neurokinin-1 Receptors
Dogs
Bearings (structural)
Safety
Animals
Neurons
Animal Models
Substantia Gelatinosa
Spinal Injections
Glial Fibrillary Acidic Protein
Hyperalgesia
Neuralgia
Motor Neurons
Horns
Dendrites
substance P-saporin
Toxicity
Rats
Rodentia

Keywords

  • Neurokinin 1 receptor
  • Neurotoxin
  • Saporin
  • Spinal
  • Substance P

ASJC Scopus subject areas

  • Toxicology

Cite this

Allen, J. W., Mantyh, P. W., Horais, K., Tozier, N., Rogers, S. D., Ghilardi, J. R., ... Yaksh, T. L. (2006). Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs. Toxicological Sciences, 91(1), 286-298. https://doi.org/10.1093/toxsci/kfj143

Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs. / Allen, Jeffrey W.; Mantyh, Patrick W.; Horais, Kjersti; Tozier, Nicole; Rogers, Scott D.; Ghilardi, Joseph R.; Cizkova, Dasa; Grafe, Marjorie; Richter, Phillip; Lappi, Douglas A.; Yaksh, Tony L.

In: Toxicological Sciences, Vol. 91, No. 1, 05.2006, p. 286-298.

Research output: Contribution to journalArticle

Allen, JW, Mantyh, PW, Horais, K, Tozier, N, Rogers, SD, Ghilardi, JR, Cizkova, D, Grafe, M, Richter, P, Lappi, DA & Yaksh, TL 2006, 'Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs', Toxicological Sciences, vol. 91, no. 1, pp. 286-298. https://doi.org/10.1093/toxsci/kfj143
Allen JW, Mantyh PW, Horais K, Tozier N, Rogers SD, Ghilardi JR et al. Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs. Toxicological Sciences. 2006 May;91(1):286-298. https://doi.org/10.1093/toxsci/kfj143
Allen, Jeffrey W. ; Mantyh, Patrick W. ; Horais, Kjersti ; Tozier, Nicole ; Rogers, Scott D. ; Ghilardi, Joseph R. ; Cizkova, Dasa ; Grafe, Marjorie ; Richter, Phillip ; Lappi, Douglas A. ; Yaksh, Tony L. / Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs. In: Toxicological Sciences. 2006 ; Vol. 91, No. 1. pp. 286-298.
@article{3b567088da9443e095736948579b218d,
title = "Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs",
abstract = "Intrathecal (IT) substance P-Saporin (SP-SAP), a 33-kDa-targeted neurotoxin, produces selective destruction of superficial neurokinin 1 receptor (NK1r)-bearing cells in the spinal dorsal horn. In rats, SP-SAP prevents the formation of hyperalgesia and can reverse established neuropathic pain behavior in rodents. To determine the safety of this therapeutic modality in a large animal model, beagles received bolus IT lumbar injections of vehicle, SP-SAP (1.5, 15, 45, or 150 μg), or a nontargeted preparation of saporin (SAP, 150 μg) for immunohistological analysis of spinal cords. Doses of 15 μg SP-SAP and above produced a significant and equivalent loss of NK1r-bearing cells and dendrites in lumbar laminae II and I compared to vehicle- or SAP-treated animals. Cervical regions in all animals displayed no loss of NK1r immunoreactivity as compared to controls. Total numbers of neurons in the lumbar dorsal horn or alpha-motor neurons in the ventral horn demonstrated no significant changes. No increases in the astrocytic marker glial fibrillary acidic protein were noted following treatment with SP-SAP, suggesting a lack of generalized neurotoxicity. Additional dogs received doses of 1.5-150 μg SP-SAP or SAP and were sacrificed after 28 or 90 days to assess behavioral and physiological parameters. Although some acute motor signs were observed with both SP-SAP and SAP, no long-lasting significant events were noted in any of these animals. These data indicate no adverse toxicity at doses up to 10 times those necessary for producing loss of superficial NK1r-bearing neurons in a large animal model.",
keywords = "Neurokinin 1 receptor, Neurotoxin, Saporin, Spinal, Substance P",
author = "Allen, {Jeffrey W.} and Mantyh, {Patrick W.} and Kjersti Horais and Nicole Tozier and Rogers, {Scott D.} and Ghilardi, {Joseph R.} and Dasa Cizkova and Marjorie Grafe and Phillip Richter and Lappi, {Douglas A.} and Yaksh, {Tony L.}",
year = "2006",
month = "5",
doi = "10.1093/toxsci/kfj143",
language = "English (US)",
volume = "91",
pages = "286--298",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Safety evaluation of intrathecal substance P-Saporin, a targeted neurotoxin, in dogs

AU - Allen, Jeffrey W.

AU - Mantyh, Patrick W.

AU - Horais, Kjersti

AU - Tozier, Nicole

AU - Rogers, Scott D.

AU - Ghilardi, Joseph R.

AU - Cizkova, Dasa

AU - Grafe, Marjorie

AU - Richter, Phillip

AU - Lappi, Douglas A.

AU - Yaksh, Tony L.

PY - 2006/5

Y1 - 2006/5

N2 - Intrathecal (IT) substance P-Saporin (SP-SAP), a 33-kDa-targeted neurotoxin, produces selective destruction of superficial neurokinin 1 receptor (NK1r)-bearing cells in the spinal dorsal horn. In rats, SP-SAP prevents the formation of hyperalgesia and can reverse established neuropathic pain behavior in rodents. To determine the safety of this therapeutic modality in a large animal model, beagles received bolus IT lumbar injections of vehicle, SP-SAP (1.5, 15, 45, or 150 μg), or a nontargeted preparation of saporin (SAP, 150 μg) for immunohistological analysis of spinal cords. Doses of 15 μg SP-SAP and above produced a significant and equivalent loss of NK1r-bearing cells and dendrites in lumbar laminae II and I compared to vehicle- or SAP-treated animals. Cervical regions in all animals displayed no loss of NK1r immunoreactivity as compared to controls. Total numbers of neurons in the lumbar dorsal horn or alpha-motor neurons in the ventral horn demonstrated no significant changes. No increases in the astrocytic marker glial fibrillary acidic protein were noted following treatment with SP-SAP, suggesting a lack of generalized neurotoxicity. Additional dogs received doses of 1.5-150 μg SP-SAP or SAP and were sacrificed after 28 or 90 days to assess behavioral and physiological parameters. Although some acute motor signs were observed with both SP-SAP and SAP, no long-lasting significant events were noted in any of these animals. These data indicate no adverse toxicity at doses up to 10 times those necessary for producing loss of superficial NK1r-bearing neurons in a large animal model.

AB - Intrathecal (IT) substance P-Saporin (SP-SAP), a 33-kDa-targeted neurotoxin, produces selective destruction of superficial neurokinin 1 receptor (NK1r)-bearing cells in the spinal dorsal horn. In rats, SP-SAP prevents the formation of hyperalgesia and can reverse established neuropathic pain behavior in rodents. To determine the safety of this therapeutic modality in a large animal model, beagles received bolus IT lumbar injections of vehicle, SP-SAP (1.5, 15, 45, or 150 μg), or a nontargeted preparation of saporin (SAP, 150 μg) for immunohistological analysis of spinal cords. Doses of 15 μg SP-SAP and above produced a significant and equivalent loss of NK1r-bearing cells and dendrites in lumbar laminae II and I compared to vehicle- or SAP-treated animals. Cervical regions in all animals displayed no loss of NK1r immunoreactivity as compared to controls. Total numbers of neurons in the lumbar dorsal horn or alpha-motor neurons in the ventral horn demonstrated no significant changes. No increases in the astrocytic marker glial fibrillary acidic protein were noted following treatment with SP-SAP, suggesting a lack of generalized neurotoxicity. Additional dogs received doses of 1.5-150 μg SP-SAP or SAP and were sacrificed after 28 or 90 days to assess behavioral and physiological parameters. Although some acute motor signs were observed with both SP-SAP and SAP, no long-lasting significant events were noted in any of these animals. These data indicate no adverse toxicity at doses up to 10 times those necessary for producing loss of superficial NK1r-bearing neurons in a large animal model.

KW - Neurokinin 1 receptor

KW - Neurotoxin

KW - Saporin

KW - Spinal

KW - Substance P

UR - http://www.scopus.com/inward/record.url?scp=33645814178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645814178&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfj143

DO - 10.1093/toxsci/kfj143

M3 - Article

C2 - 16500924

AN - SCOPUS:33645814178

VL - 91

SP - 286

EP - 298

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -